Coherus Biosciences | CHRS - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
AbbVie USD 3.59B 28.65B 2025-12
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
Akebia Therapeutics USD 9.42M 1.04M 2026-06
ALKERMES USD 142.86M 40.5M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amarin USD 18.8M 29.36M 2026-06
Amgen USD 2.86B 16.65B 2026-06
Baxter International USD 1.03B 52M 2026-06
Biogen USD 403.9M 45.4M 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Coherus Biosciences USD 13.17M 1.69M 2026-06
Eli Lilly USD 6.11B 1.08B 2026-06
Fujifilm JPY 292.7B 15.36B 2026-03
Gilead Sciences USD 645M 70M 2026-03
Ironwood Pharmaceuticals USD 3.24M 339K 2026-03
Merck USD 3.83B 36M 2026-06
Myriad Genetics USD 30.4M 2.2M 2026-06
Pacira USD 17.51M 3.5M 2026-06
Perrigo USD 400.4M 34.4M 2026-06
Pfizer USD 4.58B 75M 2026-06
PTC Therapeutics USD 40.45M 14.96M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Teva Pharmaceutical Industries USD 2.72B 125M 2026-06
Vertex Pharmaceuticals USD 3.61B 135M 2026-06
Xencor USD 12.65M 4.73M 2026-06
Zoetis USD 452M 55M 2026-06